UNSPSC 51373319: Aspirin/butalbital/caffeine/codeine

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class CN101. This VA Drug Class (CN101) classifies this compound as belonging to the group OPIOID ANALGESICS.

UNSPSC 51373319 Aspirin/butalbital/caffeine/codeine is a Commodity code that in recent state and local procurement activity does not reflect purchases aligned with its nominal scope. The single recent opportunity posted under this code—Seminole County, Florida's IFB 60459723LAS—solicits naloxone and safe drug deactivation systems, which fall outside the pharmaceutical combination therapy products the code nominally describes. The mismatch suggests either a coding error in the county's procurement system or a tagging anomaly in the data source. State and local procurement activity under this code shows little to no recent relevant activity in alignment with its intended commodity classification.

Seminole County's June 30, 2026 posting sought 1,900 units of naloxone and 800 safe drug deactivation systems annually through competitive bidding, with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida and a response deadline of July 26, 2023. The procurement required electronic bid submission through the county's e-Procurement Portal, included shipping and delivery costs in vendor proposals, and mandated E-Verify compliance and drug-free workplace certification. The contract terms included an initial two-year period with a one-year renewal option and compliance with federal regulations due to potential FEMA funding. Without additional recent opportunities tagged to this code from other jurisdictions, geographic concentration or issuing-body patterns cannot be established, and the code does not support a meaningful market assessment for vendors pursuing state and local contracts aligned with the aspirin/butalbital/caffeine/codeine commodity classification.